BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6125676)

  • 1. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya.
    Plummer FA; Maggwa N; D'Costa LJ; Nsanze H; Karasira P; Maclean IW; Ronald AR
    Sex Transm Dis; 1984; 11(4):304-7. PubMed ID: 6098034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of chancroid.
    Schmid GP
    JAMA; 1986 Apr; 255(13):1757-62. PubMed ID: 3512872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
    Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
    J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.
    Girouard YC; Maclean IW; Ronald AR; Albritton WL
    Antimicrob Agents Chemother; 1981 Jul; 20(1):144-5. PubMed ID: 6974538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim.
    Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR
    Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
    Ball AP; Geddes AM; Davey PG; Farrell ID; Brookes GR
    Lancet; 1980 Mar; 1(8169):620-3. PubMed ID: 6102627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis.
    Ulmer WT; Zimmermann I
    J Int Med Res; 1981; 9(5):372-7. PubMed ID: 7028534
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole.
    Fast MV; Nsanze H; Plummer FA; D'Costa LJ; MacLean IW; Ronald AR
    Br J Vener Dis; 1983 Oct; 59(5):320-4. PubMed ID: 6351957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.
    Bodhidatta L; Taylor DN; Chitwarakorn A; Kuvanont K; Echeverria P
    Antimicrob Agents Chemother; 1988 May; 32(5):723-5. PubMed ID: 3293526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three day oral course of Augmentin to treat chancroid.
    Ndinya-Achola JO; Nsanze H; Karasira P; Fransen L; D'Costa LJ; Piot P; Ronald AR
    Genitourin Med; 1986 Jun; 62(3):202-4. PubMed ID: 3733082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly.
    Gallacher G; Erwin L; Scott PJ; Sleigh JD
    J Infect; 1986 May; 12(3):229-33. PubMed ID: 3522749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
    Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
    Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
    Lapointe JR; Lavallée C
    J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes.
    Van Klingeren B; Dessens-Kroon M
    J Antimicrob Chemother; 1979 May; 5(3):322-3. PubMed ID: 314442
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chancroid, 1989.
    Schmid GP
    Rev Infect Dis; 1990; 12 Suppl 6():S580-9. PubMed ID: 2201074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.